XSNX (Novaccess Global) Cyclically Adjusted PB Ratio: (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSNX Novaccess Global Inc XSNX
12 GF Score
Price $0.00
View Full Analysis

What is Novaccess Global Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Novaccess Global  (OTCPK:XSNX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Novaccess Global Cyclically Adjusted PB Ratio Related Terms


Novaccess Global Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Novaccess Global's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novaccess Global Cyclically Adjusted PB Ratio Chart

Novaccess Global Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Novaccess Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XSNX vs NBIO, BTAX, PXMD: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Novaccess Global's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novaccess Global Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novaccess Global's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novaccess Global's Cyclically Adjusted PB Ratio falls into.


XSNX
12GF Score
Novaccess Global Inc XSNX
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novaccess Global Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Novaccess Global's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Novaccess Global's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book=Book Value per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.163/315.3010*315.3010
=-0.163

Current CPI (Sep. 2024) = 315.3010.

Novaccess Global Quarterly Data

Book Value per Share CPI Adj_Book
201412 -1.489 234.812 -1.999
201503 -1.087 236.119 -1.452
201506 -0.836 238.638 -1.105
201509 -1.247 237.945 -1.652
201512 -1.292 236.525 -1.722
201603 -0.860 238.132 -1.139
201606 -1.011 241.018 -1.323
201609 -1.073 241.428 -1.401
201612 -0.954 241.432 -1.246
201703 -0.856 243.801 -1.107
201706 -0.756 244.955 -0.973
201709 -1.004 246.819 -1.283
201712 -0.712 246.524 -0.911
201803 -0.907 249.554 -1.146
201806 -5.365 251.989 -6.713
201809 -3.159 252.439 -3.946
201812 -2.099 251.233 -2.634
201903 -1.659 254.202 -2.058
201906 -1.946 256.143 -2.395
201909 -1.396 256.759 -1.714
201912 -1.459 256.974 -1.790
202003 -1.435 258.115 -1.753
202006 -0.744 257.797 -0.910
202009 -2.227 260.280 -2.698
202012 -0.194 260.474 -0.235
202103 -0.211 264.877 -0.251
202106 -0.330 271.696 -0.383
202109 -0.273 274.310 -0.314
202112 -0.272 278.802 -0.308
202203 -0.262 287.504 -0.287
202206 -0.248 296.311 -0.264
202209 -0.249 296.808 -0.265
202212 -0.346 296.797 -0.368
202303 -0.270 301.836 -0.282
202306 -0.289 305.109 -0.299
202309 -0.359 307.789 -0.368
202312 -0.268 306.746 -0.275
202403 -0.225 312.332 -0.227
202406 -0.120 314.175 -0.120
202409 -0.163 315.301 -0.163

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novaccess Global Business Description

Address 459 Columbus Avenue, No. 607, New York, NY, USA, 10024
Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.
12GF Score

Get the complete analysis for XSNX

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price